Predictors of Depression Treatment Response to Exercise
1 other identifier
interventional
38
1 country
1
Brief Summary
50 subjects with Major Depressive Disorder who are not currently receiving treatment will be enrolled in a 12-week exercise program, supervised by a trained exercise interventionist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 depression
Started Dec 2015
Typical duration for phase_3 depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2015
CompletedFirst Posted
Study publicly available on registry
October 22, 2015
CompletedStudy Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedApril 1, 2019
March 1, 2019
3.2 years
October 13, 2015
March 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Depressive Symptoms
Depressive symptoms will be assessed using the clinician-rated Inventory for Depressive Symptomatology (IDS-C)
12 weeks
Study Arms (1)
Exercise
EXPERIMENTALParticipants will complete an exercise dose of 15 kilocalories per kilogram of bodyweight per week (KKW). This is equivalent to approximately 150 minutes/week of aerobic exercise. This dose will be completed in at least 3 sessions per week for 12 weeks.
Interventions
Subjects will engage in supervised exercise sessions for 12 weeks. Each week will consist of at least three exercise sessions with a total duration of weekly exercise of approximately 150 minutes.
Eligibility Criteria
You may qualify if:
- Diagnosed with MDD
- Ages 18-65 will be included.
- Ability to understand and willingness to provide written informed consent.
- Willing to provide contact information.
- Medical clearance with protocol-defined stress testing (in accordance with American College of Sports Medicine (ACSM) guidelines) from protocol approved medical personnel. Details of guidelines and related testing protocol are provided in the study Manual of Procedures.
- Able to comprehend and communicate in English.
You may not qualify if:
- Have a medical condition contraindicating exercise participation
- Are currently physically active - defined as moderate intensity physical activity on 3 or more days per week for the last month
- Currently receiving antidepressant medication treatment
- Currently considered a high suicide risk and/or high risk for being unable to complete the study due to the need for psychiatric hospitalization, suicide attempts or suicidality, significant self-mutilation, or other self-injurious or destructive behavior based on the judgment of the site PI, medical personnel, or designee.
- Pregnancy.
- Current psychotic disorder. Other comorbid psychiatric diagnosis that, in the investigator's judgment, will pose a safety issue or make it difficult for the participant to understand or complete the intervention.
- Anticipated circumstances over the 6-month course of the trial that would render the participant unlikely to complete the study in the judgment of the PI or designee.
- Any reason not listed herein yet, determined by the PI, medical personnel, or designee that constitutes good clinical practice and that would in the opinion of the PI, medical personnel, or designee make participation in the study hazardous.
- Are currently enrolled in another research study, and participation in that study contraindicates participation in the current study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT Southwestern Medical Center
Dallas, Texas, 75390-9119, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chad Rethorst, PhD
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2015
First Posted
October 22, 2015
Study Start
December 1, 2015
Primary Completion
February 1, 2019
Study Completion
February 1, 2019
Last Updated
April 1, 2019
Record last verified: 2019-03